Krishna Udayakumar, MD, MBA - Duke Global Health Institute



Krishna Udayakumar, MD, MBA

Curriculum Vitae

CONTACT INFORMATION

| |Physical Address: |

| |324 Blackwell Street, Suite 960 (Washington Building) |

| |Durham, NC 27701 |

| |Office: 919-668-8585 |

| |Mobile: 919-699-6024 |

| |ku@duke.edu |

| | |

EDUCATION

|1999-2004 |Doctor of Medicine, Duke University School of Medicine, Durham, North Carolina |

|2001-2004 |Master of Business Administration with Concentration in Health Sector Management, Duke University, The Fuqua|

| |School of Business, Durham, North Carolina |

|1995-1999 |Bachelor of Arts with Distinction in Interdisciplinary Studies, University of Virginia, Charlottesville, |

| |Virginia |

APPOINTMENTS

|January 2014 to |Associate Professor of Global Health and Medicine, Duke University, Durham, North Carolina |

|present | |

|January 2017 to |Associate Professor, Duke-NUS Medical School, Singapore |

|present | |

|March 2011 to December|Assistant Professor, Duke-NUS Medical School, Singapore |

|2016 | |

|January 2011 to |Assistant Professor of Global Health and Medicine, Duke University, Durham, North Carolina |

|December 2013 | |

| | |

|September 2007 to |Assistant Professor of Medicine, Duke University, Durham, North Carolina |

|December 2010 | |

| | |

|April 2007 to June |Assistant Chief Resident, Durham VA Medical Center |

|2007 |Department of Medicine, Duke University Medical Center, Durham, North Carolina |

EMPLOYMENT

|July 2007 to Present |Duke University, Durham North Carolina |

| | |

| |Head of Global Innovation, Duke Health; Associate Vice President, Duke University (November 2011-present) |

| |Director, Office of Duke Medicine Global (March 2010-October 2011) |

| | |

| |Responsible for the development and implementation of global strategy as well as global business development|

| |across Duke Health, positioning global engagement as platform for innovation and bi-directional learning |

| |Grow and lead team responsible for these functions, creating financial sustainability for group through |

| |generation of external revenue |

| |Lead efforts to develop and implement global programs, including advisory services as well as leadership and|

| |management training for diverse audiences |

| |Develop strategic and entrepreneurial relationships and collaborations with leading multi-national |

| |corporations, health systems, foundations, and public sector organizations to support institutional mission |

| |Work closely with senior leaders across Duke Health to expand Duke’s international activities and develop |

| |global partnerships across translational and clinical research, global health, education and training, |

| |healthcare delivery, healthcare management, and related areas |

| |Support collaborations between Duke Health and Duke-NUS Medical School Singapore, developing research and |

| |education links between campuses in US and Singapore |

| |Support the growth of clinical innovation at Duke-NUS and the establishment of a partnership for academic |

| |medicine with SingHealth in Singapore |

| |Played leading role in planning and establishment efforts for Duke Institute for Health Innovation, launched|

| |in 2013 to promote transformative change in health and healthcare through innovation and entrepreneurship, |

| |focused on health delivery science, technology innovation, workforce and leadership development, and applied|

| |health policy |

| |Supported establishment of Duke-Margolis Center for Health Policy, and serve as core faculty member in |

| |development of new health policy initiatives across Duke University |

| |Led efforts to establish the Medanta Duke Research Institute, a joint venture company in India dedicated to |

| |conducting proof-of-concept clinical research, from conceptual planning to negotiating agreements to |

| |supervising implementation of program |

| |Led Duke’s collaboration with Singapore Clinical Research Institute, directing a team from Duke to develop a|

| |national Academic Clinical Research Organization in Singapore, on behalf of the Ministry of Health and |

| |National Medical Research Council of Singapore |

| |Led collaboration with Nazarbayev University and National Medical Holding in Astana, Kazakhstan, to provide |

| |strategic guidance on the development on an Integrated Academic Health System in Central Asia |

| | |

| | |

| |President and Executive Director, Innovations in Healthcare – formerly International Partnership for |

| |Innovative Healthcare Delivery (April 2011-present; interim capacity April 2011-February 2012) |

| |Director, Duke Global Health Innovation Center (February 2017-present) |

| |Lead Innovations in Healthcare, a non-profit co-founded by Duke Health, McKinsey & Company, and the World |

| |Economic Forum, with the vision of supporting the scale and replication of transformative healthcare |

| |innovations globally, since its inception |

| |Provide strategic and operational direction and oversight for all work of the organization, focused on |

| |improving health and healthcare globally by curating and scaling proven innovations |

| |Lead programs and projects supporting health innovation in the US by leveraging global lessons and best |

| |practices |

| |Work directly with 70+ social enterprises around the world as well as collaborators from industry, academia,|

| |foundations, and governments to facilitate the growth of transformative models of care across developing and|

| |developed economies |

| |Establish and lead Global Health Innovation Center to deepen academic efforts to support health innovation |

| |globally, formally linking Duke Global Health Institute with Duke-Margolis Center for Health Policy and Duke|

| |Institute for Health Innovation |

| |Co-Principal Investigator on collaborative agreement with USAID establishing the Social Entrepreneurship |

| |Accelerator at Duke ($12mm over five years) to support scaling of global health social enterprises, |

| |especially focused on India and East Africa |

| |Served as advisor to Massachusetts Health Policy Commission’s Health Care Innovation Investment Program; to |

| |USAID for Saving Lives at Birth innovation program; to Network for Excellence in Health Innovation for |

| |Global Lab for Health program |

| |Contributed to development and growth of Amsterdam Health and Technology Institute, including Living Labs |

| |for health innovation in US, Netherlands, China, and Kenya |

| |Support World Innovation Summit for Health (WISH) in Qatar through content development in human capital |

| |innovation in health as well as accountable care |

| | |

| |Associate Professor of Global Health and Medicine (January 2014-present) |

| |Assistant Professor of Global Health and Medicine (January 2011-December 2013) |

| |Assistant Professor of Medicine (September 2007-December 2010) |

| |Member, Duke Global Health Institute (April 2010-December 2010) |

| |Serve as Associate Program Director for the Management and Leadership Pathway for Residents, a |

| |first-of-its-kind graduate medical education program combining clinical and management training, targeting |

| |physicians with graduate management degrees |

| |Mentor students from School of Medicine, Fuqua School of Business, and Duke Global Health Institute on |

| |research projects in global health |

| |Provide medical care and supervise house staff and students on General Medicine services at Duke University |

| |Hospital, Duke Regional Hospital, and Durham VA Medical Center |

| |Co-led Bass Connections course on global health program evaluation, aligned with SEAD efforts in East Africa|

| |Served as founding member of the Duke Medicine Initiative on Health Innovations, working with the Chancellor|

| |for Health Affairs to develop new programs aimed at transformative innovations in health care delivery and |

| |training and planning the launch of the new Duke Institute for Health Innovation |

| |Coordinated Health Policy lecture series for internal medicine house staff |

| |Served as Co-Course Director for clinical core in Health Policy and Economics for second-year medical |

| |students |

| | |

| |Strategy, Business Development, and Special Projects, Duke Translational Medicine Institute (September 2007 |

| |to June 2012) |

| |Senior Strategic Services Associate, Duke Translational Medicine Institute (July 2007 – August 2007) |

| |Provided business strategy and business development support and led special projects for Duke Translational |

| |Medicine Institute |

| |Led institutional efforts to restructure biobanking infrastructure across campus, resulting in Memorandum of|

| |Understanding creating a central governance structure for biobanking activities; Served on the Duke Biobank |

| |Steering Committee |

| |Served on Leadership Group of the MURDOCK Study, a large-scale genomic epidemiology project supported by |

| |$35mm gift from David H. Murdock |

| |Facilitated Duke initiatives with North Carolina Research Campus in Kannapolis, North Carolina |

|June 2004 to June 2007|Duke University Medical Center, Durham, North Carolina |

| |Categorical Internal Medicine Resident |

| |Provided direct patient care in inpatient and outpatient settings at Duke University Hospital, Durham VA |

| |Medical Center, Duke Regional Hospital, and multiple clinic locations |

| |Supervised multiple members of healthcare team in patient care situations |

| |Elected by peers as member of Residency Council 2004-2005 |

|April 2002 to March |Campbell Alliance, Inc., Raleigh, North Carolina |

|2003 |Independent Consultant |

| |Leveraged medical and business skills to analyze pharmaceutical marketing effectiveness for multiple clients|

| | |

| |Assessed sales representatives nation-wide through one-on-one phone interactions to ensure quality and |

| |consistency of sales messages |

|1995 to 1997 |Lee County Community Hospital, Pennington Gap, Virginia |

| |Assistant to Administration |

| |Worked full-time during academic breaks at health system comprising 80-bed hospital and multiple outpatient |

| |clinics |

| |Led interdepartmental team in development of health system’s corporate compliance and ethics policies and |

| |procedures |

| |Reported directly to CEO, COO, and Board of Directors |

| |Successfully implemented policies through employee education efforts |

| |Protected organization from liability for $8M in healthcare fraud by individuals within organization |

CERTIFICATION AND LICENSURE

|2007 to 2027 |Certification in Internal Medicine, American Board of Internal Medicine |

| |-Initial certification in 2007; Recertification in 2017 |

|2007 to 2018 |North Carolina Unrestricted Medical License, Active |

| |2007-01138 |

PROFESSIONAL MEMBERSHIPS

|2006 to present |Member of the American College of Physicians |

|2010 to 2014 |Member of the Society for Clinical and Translational Science |

HOSPITAL CREDENTIALS

|2008 to present |Durham Veterans’ Affairs Medical Center, Durham, North Carolina |

|2007 to |Duke University Hospital, Durham, North Carolina |

|2011 | |

|2007 to |Duke Regional Hospital, Durham, North Carolina |

|2010 | |

HONORS AND AWARDS

|2003 |Sax/Baldridge Award, Fuqua School of Business, Duke University |

|2003 |Fuqua Scholar, Fuqua School of Business, Duke University |

|2001 to 2003 |Dean’s List, Fuqua School of Business, Duke University |

|1999 |Phi Beta Kappa, University of Virginia |

|1995 to 1999 |Dean’s List, University of Virginia |

|1995 to 1999 |Echols Scholar, University of Virginia |

|1995 to 1999 |Alumni Scholar, University of Virginia |

|1995 to 1999 |Columbia/HCA Scholar, University of Virginia |

OTHER CERTIFICATES

|2006 |Certificate of Completion, Course in Clinical Teaching, Duke University Medical Center, Durham, North |

| |Carolina |

|2005 |Certificate of Completion, Course in Medical Decision-Making, Duke University Medical Center, Durham, North |

| |Carolina |

PRESENTATIONS

| |External Oral Presentations |

|2017 |Udayakumar K and Roan C, “Partnerships and the Private Sector: New Innovations in Global Health.” Atlantic |

| |Live event – The Power of Purpose: Corporate Responsibility Summit, New York, New York. |

|2017 |Udayakumar K, and Egger J, “Social Entrepreneurship Accelerator at Duke,” Presentation to USAID Higher |

| |Education Solutions Network Lab Directors Meeting, Washington, D.C. |

|2017 |Udayakumar K, “Transforming health and healthcare globally through innovation.” Presentation to University |

| |of North Carolina Kenan-Flagler Business School class, Global Healthcare Management, Chapel Hill, North |

| |Carolina. |

|2017 |Udayakumar K, “Innovative strategies for scaling health care in low-resource settings,” Webinar presentation|

| |to Asian Venture Philanthropy Network. |

|2017 |Udayakumar K, “Applying global innovations in the U.K.” Learning from WISH: A Forum on Accountable Care, |

| |London, England, UK. |

|2017 |Udayakumar K, “Reimagined in America: What can the world teach us?” Webinar presentation for Robert Wood |

| |Johnson Foundation. |

|2017 |Udayakumar K, “Beyond talking points: Global health considerations for the new administration and Congress.”|

| |Moderator for panel discussion for series hosted by Duke in DC Office, Washington, DC. |

|2017 |Udayakumar K, “Social Entrepreneurship Accelerator at Duke.” Presentation to USAID Global Health Bureau and |

| |Global Development Lab, Washington, DC. |

|2016 |Udayakumar K, “Facilitating global faculty engagement: entrepreneurial and industry collaborations.” |

| |Association of International Education Administrators Thematic Forum on Leveraging Industry Partnerships in |

| |a Global Context for Student and Faculty Success, North Carolina State University, Raleigh, North Carolina. |

|2015 |Udayakumar K, “Reverse innovation: pathways for adoption and adaptation.” UCLA Health Global Lab for |

| |Innovation international meeting, Los Angeles, California. |

|2015 |Udayakumar K, “Scaling innovations to improve health and healthcare through public-private partnerships.” |

| |World Bank presentation, Washington, DC. |

|2014 |Udayakumar K, “Increasing access to quality, affordable healthcare through innovation.” Keynote address, |

| |Novartis Foundation annual symposium, Basel, Switzerland. |

|2014 |Udayakumar K, “Supporting global health innovation.” Speaker and panelist at Global Mental Health Workshop |

| |organized by National Institute of Mental Health and Grand Challenges Canada, Bethesda, Maryland. |

|2014 |Panelist, “Global Breakfast Panel: Challenges (and lessons learned?) from Northern Europe to developing |

| |nations.” Health Evolution Partners Summit, Dana Point, California. |

|2014 |Speaker and panel moderator, “Global lab for innovation: leveraging successful innovations across domestic |

| |and international markets.” Health Evolution Partners Summit, Dana Point, California. |

|2014 |Udayakumar K, “Transforming health and healthcare through innovation.” Special address at The Future of |

| |Healthcare: A Collective Vision, New Delhi, India. |

|2014 |Expert respondent and panelist, “Unconventional and disruptive technology interventions for healthcare.” |

| |Sankalp Africa Summit, Nairobi, Kenya. |

|2014 |Co-chair of conference and keynote speaker, “Enabling human capital innovation.” Healthcare Innovation |

| |Summit, Arab Health 2014, Dubai, United Arab Emirates. |

|2013 |Speaker on social innovation, TALK: Global Social Innovation Forum, Shanghai, China. |

|2013 |Udayakumar K, “Delivering Innovation in Healthcare Delivery.” Singapore Management University – Johnson & |

| |Johnson Hospital Management Program, Singapore. |

|2012 |Panel Moderator, International Partnership for Innovative Healthcare Delivery Annual Innovator-Investor |

| |Conference; Washington, DC. |

|2012 |Session Chair on Innovative Models of Healthcare Delivery; COHRED Forum 2012, Cape Town, South Africa. |

|2011 |Panel Moderator, World Healthcare Congress Latin America, Rio de Janeiro, Brazil. |

|2011 |Panel Moderator, Innovation in Healthcare, Council on Competitiveness 12th US-Brazil Innovation Learning |

| |Laboratory, Durham, North Carolina. |

|2011 |Udayakumar K, “Globalization of Academic Medicine: Opportunities and Challenges.” Invited lecture by Provost|

| |as part of Innovations in Higher Education Speaker Series, University of Alabama at Birmingham. |

|2011 |Udayakumar K, “Globalization of Academic Medicine: Opportunities and Challenges.” Invited lecture by |

| |President, Baylor College of Medicine, Houston, Texas. |

|2010 |Udayakumar K, “Global Lessons from Innovation in India.” Plenary session, FICCI-HEAL (Federation of Indian |

| |Chambers of Commerce and Industry, Health-Enterprise and Learning) Conference, New Delhi, India |

|2008 |Udayakumar K, “Personalized Medicine: The Kannapolis Story.” Society for Cryobiology Plenary Session, |

| |Charlotte, North Carolina |

|2003 |Udayakumar K, “Overview of the Duke Cardiomics Network.” Genetics and Cardiovascular Disease Roundtable, |

| |Washington, DC |

| | |

| |Intramural Oral Presentations |

| | |

|2017 |Udayakumar K, “Global health innovation.” Presentation to DGHI course, Entrepreneurial problem solving in |

| |global health, Durham, North Carolina. |

|2017 |Udayakumar K, “Duke Global Health Innovation Center.” Presentation to Duke University Global Priorities |

| |Committee, Durham, North Carolina. |

|2017 |Udayakumar K, “Transforming health through innovation.” Presentation to Duke University Alumni Associate |

| |Board of Directors, Durham, North Carolina. |

|2017 |Udayakumar K, “Overview of Duke-NUS Medical School.” Presentation to Kazakhstan medical universities |

| |leadership program, Durham, North Carolina. |

|2017 |Udayakumar K, “Global Activities.” Presentation to Duke University Health System Executive Management |

| |Committee, Durham, North Carolina. |

|2017 |Udayakumar K, “Duke Global Health Innovation Center.” Presentation to Duke University Global Priorities |

| |Committee, Durham, North Carolina. |

|2017 |Udayakumar K, “Partnership evolutions: East Africa.” Panelist for discussion with Duke Global Health |

| |Institute Board of Advisors, Durham, North Carolina. |

|2017 |Udayakumar K, “Global health innovation.” Lecture for Public Policy course, Value for Money, Duke |

| |University, Durham, North Carolina. |

|2016 |Udayakumar K, “Health system innovation.” Presentation to senior leaders from SingHealth, Singapore. |

|2015 |Udayakumar K, “Transforming health and healthcare globally through innovation.” Lecture to Fuqua School of |

| |Business Health Sector Management students and to Master of Management in Clinical Informatics students, |

| |Durham, North Carolina |

|2014 |Udayakumar K, “Supporting health innovation globally.” Lecture to all second-year medical students at Duke |

| |University School of Medicine, Durham, North Carolina |

|2013 |Panelist, Implementation and health delivery science, inaugural Duke Summit on Transformative Innovation in |

| |Healthcare. Duke University, Durham, North Carolina |

|2013 |Udayakumar K, “Health and Healthcare in Southeast Asia: |

| |Challenges and Opportunities.” Duke-NUS Seminar on Healthcare Transformation in Southeast Asia, Duke |

| |University, Durham, North Carolina |

|2013 |Dzau VJ, Udayakumar K, “Promoting transformative innovation in health.” Duke Clinical Research Institute |

| |Research Conference, Duke University, Durham, North Carolina. |

|2011 |Panel Moderator, Duke India Business Forum, “Unlocking the Potential of India’s Healthcare Industry.” Fuqua |

| |School of Business, Duke University, Durham, North Carolina |

|2010 |Udayakumar K, “Duke Medicine Global.” Medical Center Executive Committee, Duke University, Durham, North |

| |Carolina |

|2010 |Panel Moderator, Duke Inaugural Informatics Conference, “Informatics and Global Health.” Fuqua School of |

| |Business, Duke University, Durham, North Carolina |

|2010 |Panel Discussant, Duke Asia Business Conference, “Global Healthcare Trends.” Fuqua School of Medicine, Duke |

| |University, Durham, North Carolina |

| | |

|2009 |Udayakumar K, “Global Innovations in Health Care Delivery: Case Discussion – Quality Care Private Limited.” |

| |Duke Global Health Working Group, Duke University School of Medicine, Durham, North Carolina |

|2007-2009 |Udayakumar K, “Health Policy Lecture Series: Physician Payment.” Department of Medicine Internal Medicine |

| |Residency Noon Conference, Duke University Medical Center, Durham, North Carolina |

|2007 |Udayakumar, K, “Blood, Sweat, and Saline: An Introduction to Combat Medicine.” Department of Medicine Senior|

| |Resident Talk, Duke University Medical Center, Durham, North Carolina |

|2003 |Udayakumar K, Kim HJ, Patel Y, “Duke Cardiomics Network.” Duke Clinical Research Institute Research |

| |Conference, Durham, North Carolina |

| |Poster Presentations |

|2010 |Sangvai DS, Udayakumar K, McNeill D, “Management and Leadership Pathway for Residents (MLPR): Integrating |

| |World-Class Clinical Training in Internal Medicine with Hands-On Healthcare Management Experience.” 31st |

| |Annual Academic Internal Medicine Educational Conference, San Antonio, Texas |

|2006 |Joy S, Udayakumar K, “The financial costs of ‘snail mail’ to the clinical practice of medicine.” Society of |

| |General Internal Medicine, 29th Annual Meeting, Los Angeles, California |

PUBLICATIONS

|2018 |Egger J, Langsam K, Baumgartner J, Udayakumar K, Clark C, “Lessons in supporting the growth of social |

| |enterprises to improve global health.” Manuscript submitted to Annals of Public Health, currently under peer|

| |review. |

|2017 |Maru D, Maru S, Nirola I, Gonzalez-Smith J, Thoumi A, Nepal P, Chaudary P, Basnett I, Udayakumar K, |

| |McClellan M, “Accountable care reforms improve women’s and children’s health in Nepal.” Health Affairs, |

| |36(11): 1965-72. |

|2017 |McClellan M, Udayakumar K, Thoumi A, Gonzalez-Smith J, Kadakia K, Kurek N, Abdulmalik M, Darzi A, “Improving|

| |care and lowering costs: evidence and lessons from a global analysis of accountable care reforms.” Health |

| |Affairs, 36(11): 1920-27. |

|2017 |Bhatti Y, Taylor A, Harris M, Wadge H, Escobar E, Prime M, Patel H, Carter A, Parston G, Darzi A, Udayakumar|

| |K, “Global lessons in frugal innovation to improve health care delivery in the United States.” Health |

| |Affairs, 36(11): 1912-19. |

|2015 |Thoumi A, Udayakumar K, Drobnick E, Taylor A, McClellan M, "Innovation in diabetes care around the world: |

| |case studies of care transformation through accountable care reforms.” Health Affairs, 34(9): 1489-97. |

|2015 |Seidelman J, Zuo R, Udayakumar K, Gellad ZF, “Caught on capsule: Iron-deficiency anemia due to hookworm |

| |infection.” American Journal of Medicine, 129(2): 167-69. |

|2014 |Putera M, Roark R, Lopes RD, Udayakumar K, Peterson ED, Califf RM, Shah BR, “Translation of acute coronary |

| |syndrome therapies: From evidence to routine clinical practice.” American Heart Journal, 169: 266-73. |

|2013 |Dzau VJ, Cho AH, ElLaissi W, Yoediono Z, Sangvai D, Shah BR, Zaas D, Udayakumar K, “Academic Health Centers |

| |Must Transform for an Uncertain Future,” New England Journal of Medicine, 369(11): 991-3. |

|2012 |Ackerly DC, Udayakumar K, Cho AH, Dzau VJ, “Academic Health Science Centers and Global Medicine,” chapter of|

| |book, The Intersection of Policy and Leadership at Academic Health Science Centers: A Professional and |

| |Personal Guide, Radcliffe Publishing, September 2012. |

|2012 |Tenenbaum JD, Christian V, Cornish M, Dolor RJ, Dunham AA, Ginsburg GS, Kraus VB, McCarthy JJ, McHutchison |

| |JG, Nahm ML, Newby KL, Svetkey LP, Udayakumar K, Califf RM, “The MURDOCK Study: A long-term initiative for |

| |disease reclassification through advanced biomarker discovery and Integration with Electronic Health |

| |Records.” American Journal of Translational Research, 4(3): 291-301. |

|2011 |Roark RF, Shah BR, Udayakumar K, Peterson ED, “The need for transformative innovation in hypertension |

| |management.” American Heart Journal, 162: 405-11. |

|2011 |Ackerly DC, Udayakumar K, Taber RL, Merson MH, Dzau VJ, “Perspective: Global Medicine: Opportunities and |

| |challenges for Academic Health Science Systems.” Academic Medicine, 86 (9): 1093-99. |

|2011 |Ackerly DC, Sangvai DG, Udayakumar K, Shah BR, Kalman NS, Cho AH, Schulman, KA, Fulkerson WJ, Dzau VJ, |

| |“Training the next generation of physician-executives: an innovative residency pathway in management and |

| |leadership.” Academic Medicine, 86(5): 575-9. |

|2008 |Richman B, Udayakumar K, Mitchell W, Schulman K, “Lessons from India in organizational innovation: a tale of|

| |two heart hospitals.” Health Affairs, 27(5): 1260-1270. |

|2005 |Cowper PA, Udayakumar K, Sketch MH, Peterson ED, “Economic effects of prolonged clopidogrel therapy after |

| |percutaneous coronary intervention.” Journal of the American College of Cardiology. 45(3): 369-376. |

BOARDS, COMMITTEES AND ADMINISTRATIVE SERVICE

|2017 to present |Member of Duke in India Faculty Steering Committee |

|2017 to present |Member of Duke University Global Priorities Committee |

|2015 to present |Member of Steering Committee, World Economic Forum project on Value in Healthcare. |

|2014 to present |Member of World Economic Forum Global Health and Healthcare Strategy Officers community |

|2014 to 2017 |Member of Steering Committee, World Economic Forum project on Health Systems Leapfrogging |

|2016 to 2017 |Co-lead for Global Clinical Enterprise Strategic Planning initiative |

|2015 to 2016 |Co-lead for Duke Health Strategic Planning initiative for Global Health theme |

|2014 to present |Member of Board of Directors, Duke India Services Private Limited, India |

| | |

| |Duke India Services Private Limited is a Duke-wholly controlled affiliate based in India, focused on |

| |supporting Duke University activities in India. |

|2016 to present |Director, Duke Medicine Global Support Corporation, Durham, North Carolina (previously Vice President, |

| |2010-2016) |

| | |

| |Duke Medicine Global Support Corporation is a Duke-wholly owned subsidiary based in North Carolina, focused |

| |on management and oversight of Duke Health activities internationally. |

|2014 to present |Member of Board of Managers, DUHS Global, LLC |

| | |

| |DUHS Global, LLC, is a Duke University Health System -wholly controlled affiliate based in North Carolina, |

| |focused on supporting DUHS international activities. |

|2013 to present |Member of Duke University Global Travel Advisory Committee |

|2012 to present |Member of Duke University Global Administrative Steering Committee |

| | |

|2014 to 2016 |Member of Board of Directors, WorldCare Limited, Bermuda |

| | |

| |WorldCare Limited is a for-profit company incorporated in Bermuda that provides multi-disciplinary medical |

| |second opinions and related services globally. |

|2012 to 2013 |Member of Duke Medicine Enterprise Wide Planning committees: Phase One Education Redesign Committee, Phase |

| |Two Academic Committee |

|2012 |Signature Research Institutes Review Committee, Duke Global Health Institute |

|2012 |Strategic Plan Steering Committee, Duke Global Health Institute |

|2011 to present |President and Member of Board of Directors, Innovations in Healthcare (previously IPIHD) |

| | |

| |Innovations in Healthcare is a non-profit organization affiliated with Duke University with the vision of |

| |supporting the scale and replication of innovation in healthcare delivery globally. |

|2010 to present |Member of Board of Directors, Duke Medical Strategies, Inc. |

| | |

| |Duke Medical Strategies, Inc. is a Duke-wholly owned subsidiary based in North Carolina, focused on |

| |supporting entrepreneurial activities of Duke Medicine. |

|2010 to 2011 |Member of faculty search committee for Implementation Science faculty position within Duke Global Health |

| |Institute |

|2010 to present |Member of Board of Directors, Duke Medicine Asia Pte. Ltd., Singapore |

| | |

| |Duke Medicine Asia Pte. Ltd., is a Duke-wholly owned subsidiary based in Singapore, focused on business |

| |development across Asia for Duke Health as well as implementation of activities across Asia in the areas of |

| |research, education, and service delivery. |

|2010 to present |Member of Board of Directors, Duke Global, Inc., Durham, North Carolina |

| | |

| |Duke Global, Inc., is a Duke-wholly owned subsidiary based in North Carolina, for management and oversight |

| |of Duke University activities internationally. |

|2009 to 2011 |Member of Durham Health Innovations Oversight Committee, Durham, North Carolina |

|2009 to 2013 |Member of Duke Biobank Steering Committee, Duke University Medical Center, Durham, North Carolina |

|2009 |Member of Singapore Clinical Research Institute Advisory Working Group, Singapore |

|2008 to 2009 |Member of Duke University School of Medicine Curriculum Committee Task Force for Health Policy, Economics, |

| |Leadership, and Global Health, Durham, North Carolina |

|2007 to 2013 |Member of Leadership Group, MURDOCK Study, Duke University, Durham, North Carolina |

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download